Nestlé Health Science has made a further financial commitment to the microbiome with an agreement to fund development and eventually market products to treat infection and inflammatory disorders being developed by Seres Therapeutics Inc. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
